Human umbilical cord mesenchymal stem cells ameliorate liver metabolism in diabetic rats with metabolic-associated fatty liver disease

doi:10.4252/wjsc.v17.i5.105266

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (126)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-1) series.

Item

Count

PDF

HTML

Figures (1-7)

Tables (1-1)

Sum=104

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=16

May 26, 2025 (publication date) through May 29, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Stem Cells. May 26, 2025; 17(5): 105266
Published online May 26, 2025. doi: 10.4252/wjsc.v17.i5.105266

Full Size Figure Download Figure

Figure 5 Receiver operating characteristic curves for 70 key differential metabolites between the diabetes mellitus and the diabetes mellitus + human umbilical cord mesenchymal stem cells group. Diabetes mellitus group, n = 6; diabetes mellitus + human umbilical cord mesenchymal stem cells group, n = 5. ROC: Receiver operating characteristic; AUC: Area under the curve.

Citation: Zhou KB, Nie L, Wang ML, Xiao DH, Zhang HY, Yang X, Liao DF, Yang XF. Human umbilical cord mesenchymal stem cells ameliorate liver metabolism in diabetic rats with metabolic-associated fatty liver disease. World J Stem Cells 2025; 17(5): 105266
URL: https://www.wjgnet.com/1948-0210/full/v17/i5/105266.htm
DOI: https://dx.doi.org/10.4252/wjsc.v17.i5.105266